**Core Concept**
The question is testing the concept of "soft steroids," which are synthetic corticosteroids with a lower mineralocorticoid activity compared to traditional corticosteroids. These "soft steroids" are used in the management of bronchial asthma due to their potent anti-inflammatory effects without causing significant mineralocorticoid side effects.

**Why the Correct Answer is Right**
The correct answer is a type of corticosteroid that belongs to the class of "soft steroids" or "non-halogenated" corticosteroids. These compounds have a lower affinity for mineralocorticoid receptors, resulting in reduced sodium and water retention, making them a safer option for patients with bronchial asthma. The mechanism of action of these corticosteroids involves the inhibition of phospholipase A2, leading to a decrease in the production of pro-inflammatory eicosanoids, which play a crucial role in the pathophysiology of asthma.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a "soft steroid." Traditional corticosteroids like prednisolone have a higher mineralocorticoid activity, which can lead to side effects like sodium retention and hypertension.
**Option B:** This option is incorrect because it is not commonly used in the management of bronchial asthma. While it has some anti-inflammatory effects, it is not classified as a "soft steroid."
**Option C:** This option is incorrect because it is not a "soft steroid." It has a higher mineralocorticoid activity, which makes it less suitable for the treatment of bronchial asthma.

**Clinical Pearl / High-Yield Fact**
One important fact to remember is that the "soft steroids" are often used in the management of bronchial asthma due to their potent anti-inflammatory effects and lower risk of mineralocorticoid side effects. However, they should still be used with caution, especially in patients with a history of hypertension or fluid retention.

**Correct Answer:** B. Beclomethasone